Indications and Use of Isotretinoin in Facial Plastic Surgery.

Facial plastic surgery : FPS 2018 Vol.34(1) p. 75-81

Heppt MV, Kirchberger MC, Ruzicka T, Berking C, Heppt WJ

관련 도메인

Abstract

Isotretinoin is a first generation retinoid with pleiotropic effects on keratinocyte differentiation, proliferation, and activity of sebaceous glands. For years, there has been intense debate on whether the use of isotretinoin combined with cosmetic or surgical procedures is safe and potentially more efficient than either therapy alone. Due to delays in wound healing and keloid formation, conservative recommendations were not to combine isotretinoin with any plastic surgery or local treatment at 6 to 12 months after discontinuation of the drug. However, there is increasing evidence that a combination approach is not only safe, but may also provide excellent cosmetic outcomes in acne scars, sebaceous gland hyperplasia, and thick-skinned patients undergoing facial plastic surgery. In particular, low-dose regimens of isotretinoin may offer advantages over standard dosage treatments because of better tolerability and safety in long-term use adjunct with surgical interventions. In this article, the authors aim to summarize the current evidence on the use of isotretinoin in facial plastic surgery and to share their experience from selected patients.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 keratinocyte scispacy 1
합병증 keloid 켈로이드 dict 1
합병증 wound scispacy 1
약물 Isotretinoin C0022265
isotretinoin
scispacy 1
약물 low-dose C1708745
Low-Dose Treatment
scispacy 1
질환 acne C0001144
Acne Vulgaris
scispacy 1
질환 sebaceous gland hyperplasia C0406484
Sebaceous hyperplasia
scispacy 1
질환 sebaceous glands scispacy 1
기타 patients scispacy 1

MeSH Terms

Acne Vulgaris; Combined Modality Therapy; Esthetics; Female; Humans; Isotretinoin; Low-Level Light Therapy; Male; Rhytidoplasty; Risk Assessment; Surgery, Plastic; Treatment Outcome

📑 인용 관계

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문